AKO Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
26,427
-306,418
| -92% | -$124M | 0.14% | 23 |
|
|
2025
Q1 | $166M | Buy |
332,845
+19,061
| +6% | +$9.48M | 2.15% | 20 |
|
|
2024
Q4 | $163M | Sell |
313,784
-109,689
| -26% | -$57.1M | 2.26% | 20 |
|
|
2024
Q3 | $262M | Sell |
423,473
-100,775
| -19% | -$62.3M | 3.41% | 16 |
|
|
2024
Q2 | $290M | Buy |
524,248
+64,065
| +14% | +$35.4M | 3.98% | 12 |
|
|
2024
Q1 | $267M | Buy |
460,183
+296,246
| +181% | +$172M | 3.79% | 14 |
|
|
2023
Q4 | $87M | Sell |
163,937
-174,490
| -52% | -$92.6M | 1.24% | 26 |
|
|
2023
Q3 | $171M | Sell |
338,427
-7,146
| -2% | -$3.62M | 2.79% | 16 |
|
|
2023
Q2 | $180M | Sell |
345,573
-268,711
| -44% | -$140M | 2.73% | 17 |
|
|
2023
Q1 | $354M | Sell |
614,284
-33,059
| -5% | -$19.1M | 5.39% | 7 |
|
|
2022
Q4 | $356M | Sell |
647,343
-276,688
| -30% | -$152M | 5.76% | 6 |
|
|
2022
Q3 | $469M | Sell |
924,031
-288,469
| -24% | -$146M | 7.73% | 3 |
|
|
2022
Q2 | $659M | Buy |
1,212,500
+5,962
| +0.5% | +$3.24M | 9.23% | 1 |
|
|
2022
Q1 | $713M | Sell |
1,206,538
-23,361
| -2% | -$13.8M | 7.69% | 3 |
|
|
2021
Q4 | $821M | Buy |
1,229,899
+87,438
| +8% | +$58.3M | 7.99% | 4 |
|
|
2021
Q3 | $653M | Buy |
1,142,461
+158,024
| +16% | +$90.3M | 6.76% | 4 |
|
|
2021
Q2 | $497M | Buy |
984,437
+248,578
| +34% | +$125M | 5.6% | 5 |
|
|
2021
Q1 | $336M | Buy |
735,859
+206,585
| +39% | +$94.3M | 4.15% | 9 |
|
|
2020
Q4 | $247M | Buy |
529,274
+93,897
| +22% | +$43.7M | 3.18% | 15 |
|
|
2020
Q3 | $192M | Buy |
+435,377
| New | +$192M | 3.02% | 16 |
|